Investor Relations Home - Achieve Life Sciences

Investors Home

Home 2017-06-16T21:39:52+00:00

Investors Home

Achieve Life Sciences is a specialty pharmaceutical company committed to addressing the global smoking health and nicotine addiction epidemic through the development and commercialization of cytisinicline.

Click here to access our latest corporate presentation.

 

Stock Info

Recent Press Releases

Recent News
Jan 6, 2022

SEATTLE, Wash and VANCOUVER, British Columbia, January 6, 2022 — Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and...

Jan 4, 2022

Topline ORCA-2 Results expected in Q2 2022 SEATTLE, Wash and VANCOUVER, British Columbia, January 4, 2022 — Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company...

Dec 22, 2021

SEATTLE, Wash and VANCOUVER, British Columbia, December 22, 2021 - Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and...